Finance

Lists
GLMD:NASDAQ
Galmed Pharmaceuticals Ltd
$4.43
-7.13%
(-0.34) 1D
Aug 20, 3:31:10 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GLMD...
Open
$4.56
High
$4.80
Low
$4.22
Mkt. cap
5.12M
Avg. vol.
94.18K
Volume
104.54K
52-wk high
$13.20
52-wk low
$3.29
EPS
-$16.55
Shares outstanding
1.04M
No. of employees
5
Open
$4.56
High
$4.80
Low
$4.22
Mkt. cap
5.12M
Avg. vol.
94.18K
Volume
104.54K
52-wk high
$13.20
52-wk low
$3.29
EPS
-$16.55
Shares outstanding
1.04M
No. of employees
5
News stories
From web sources and news partners
About Galmed Pharmaceuticals Ltd
CEO-
Employees5
Founded2000
Headquarters-
SectorBiotechnology
Websitegalmedpharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to GLMD in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GLMD in the last 3 months
Highest
Current $4.43
(-100.00%)
Average
(-100.00%)
Lowest
(-100.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Hold
Maintained
-
-
06/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.06M
1.09M
2.10M
1.36M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.05M
1.01M
946.00K
684.00K
Operating expense
2.11M
2.10M
3.04M
2.04M
Total operating expenses
2.11M
2.10M
3.04M
2.04M
Operating income
-2.11M
-2.10M
-3.04M
-2.04M
Other non operating income
-
-
-16.00K
-
EBT including unusual items
-2.50M
-1.89M
-4.82M
-1.91M
EBT excluding unusual items
-1.97M
-1.89M
-2.79M
-1.91M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.50M
-1.89M
-4.82M
-1.91M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
140.00K
203.00K
420.00K
134.00K
Interest expense
-
-
-79.00K
-
Net interest expenses
140.00K
203.00K
341.00K
134.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.09M
-2.07M
-3.02M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps